The Serum Institute of India announced on Tuesday that it is actively developing a vaccine for Monkeypox, with positive results anticipated within a year. This initiative follows the World Health Organization’s recent declaration of the Mpox outbreak as a public health emergency of international concern. India has reported around 30 cases of Mpox since 2022, with the latest case in March 2024. The Union Health Ministry has increased scrutiny at international entry points and designated three hospitals as nodal centers for treatment.Serum Institute ‘hopeful’ of producing Mpox vaccine, says CEO Adar Poonawalla
The Serum Institute of India announced on Tuesday that it is actively developing a vaccine for Monkeypox, with positive results anticipated within a year. This initiative follows the World Health Organization’s recent declaration of the Mpox outbreak as a public health emergency of international concern. India has reported around 30 cases of Mpox since 2022, with the latest case in March 2024. The Union Health Ministry has increased scrutiny at international entry points and designated three hospitals as nodal centers for treatment.
